Cure8 research brief
Rising IBD incidence and prevalence in Asia mean more people will need long-term care, specialist services, and health-system planning. Understanding regional trends helps patients and policymakers anticipate resource needs and workforce training.
Patients with IBD in Asia; clinicians and gastroenterology services; health policy makers and planners; researchers in epidemiology and health services.
This PLoS One analysis used Global Burden of Disease 2023 data to estimate IBD (UC and CD) incidence, prevalence, DALYs, and mortality across 47 Asian countries from 1990–2023 and projected trends to 2050 using ARIMA models.
The study reports that age-standardized incidence and prevalence of IBD in Asia increased from 1990 to 2023 and are projected to keep rising to 2050, while DALY and mortality rates were broadly stable or slightly decreasing. Higher socio-demographic index (SDI) was linked to higher prevalence.
Methods included EAPC calculations, age/sex stratification, and out-of-sample validation for projections. These findings are population-level estimates based on GBD data and statistical projections; they do not provide clinical treatment guidance or individual risk predictions.
This study analyzes GBD 2023 estimates and uses ARIMA projections; results reflect modelling choices and regional data gaps. Projections to 2050 are model-based forecasts, not observed outcomes.
Review the original publication for the complete reporting, methods, and context.
Conflict statement: The authors have declared that no competing interests exist.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
The work links climate and sociodemographic context to IBD burden in tropical regions, which can influence diagnostic recognition, resource needs, and research priorities for communities where IBD is rising.
Rising IBD prevalence across Asia means more people will need diagnosis, long-term care, and health-system resources; patterns differ by country and by Crohn's disease versus ulcerative colitis, which affects planning...
This paper explores whether polygenic risk scores (PRS) predict key long-term outcomes after IBD diagnosis — notably intestinal surgery — which could be relevant for risk stratification research and future clinical tools...
